Medicine and Dentistry
Patient
100%
Malignant Neoplasm
43%
Neoplasm
36%
Clear Cell Renal Cell Carcinoma
33%
Biological Marker
32%
Pancreas Adenocarcinoma
29%
Therapeutic Procedure
28%
Combination Therapy
24%
Gene Expression
23%
Pancreas Cancer
19%
Hepatocellular Carcinoma
19%
Association
16%
Gene
16%
Carcinogenesis
15%
Age
14%
Kidney Cancer
14%
Serum
14%
Smoking
14%
Statistical Analysis
13%
Gene Expression Profiling
13%
Recurrent Disease
13%
Prostate Cancer
12%
Colorectal Cancer Screening
12%
Risk Stratification
12%
Older Adult
12%
Colitis
12%
Dysplasia
12%
Immunocompetent Cell
12%
Neoadjuvant Therapy
12%
Disease
11%
Surgery
11%
Overall Survival
11%
Inpatient
11%
Colon Mucosa
11%
Oropharyngeal Cancer
10%
Morphology
10%
Colon Adenoma
10%
Interpersonal Communication
9%
Woman
9%
Survival
9%
Meta-Analysis
9%
Development
8%
Inflammation
8%
Experience
8%
Assessment
8%
Fibrosis
8%
Chemoradiotherapy
8%
Radiation Therapy
7%
Epithelium
7%
Tissues
7%
Biochemistry, Genetics and Molecular Biology
Kinase
36%
Gene Expression
28%
Mouse
25%
Thymine-DNA Glycosylase
25%
Nested Gene
25%
Mutation
23%
Protein
20%
Sample
18%
Mutant
17%
Age
15%
Development
12%
Morphology
12%
Imatinib
12%
Methanesulfonic Acid
12%
Tumor Suppressor Gene
11%
Apoptosis
11%
Survival
10%
Cancer Cell
10%
P16
10%
PBRM1
10%
Kinome
10%
ARID1A
9%
Microarray
9%
Gene Expression Data
9%
DNA Demethylation
8%
Mass Spectrometry
8%
Wild Type
8%
P53
8%
Base Excision Repair
8%
RNA
7%
Protein Expression
7%
Gender
7%
Transcription
7%
Arginine
7%
Deamination
7%
Probe
7%
Fibroblast
7%
Enzymatic Activity
6%
Platelet Derived Growth Factor Receptor Alpha
6%
Integrin
6%
Codon
6%
Haploinsufficiency
6%
Mouse Model
6%
Heterozygote
6%
Genetic Carrier
6%
Netrin
6%
Transactivation
6%
Tuberous Sclerosis
6%
Wart Virus
6%
Cytokine Production
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gastrointestinal Stromal Tumor
12%
Solid Malignant Neoplasm
12%
Thymine DNA Glycosylase
12%
Melanoma
12%
Liver Cell Carcinoma
12%
Imatinib
12%
Diseases
12%
Chemotherapy
11%
Carcinogenesis
8%
Biological Marker
8%
Neoplasm
7%
Combination Therapy
7%
Insulin Receptor
6%
Phosphotransferase Inhibitor
6%
Ridaforolimus
6%
Histone Deacetylase Inhibitor
6%
Mouse Model
6%
Gamma Interferon
6%
Preclinical Study
6%
Papillomavirus Infection
6%
Mammalian Target of Rapamycin
6%
Rapamycin
6%
Pancreas Adenocarcinoma
6%
Transitional Cell Carcinoma
6%
Muscle Invasive Bladder Cancer
6%
Vorinostat
6%
Cisplatin
6%
Mesothelioma
6%
Programmed Cell Death
6%
Pancreas Adenocarcinoma
6%
Rash
6%
Gemcitabine
6%
HIV
6%
Nivolumab
6%
Fibrosis
6%
Cetuximab
6%
Postoperative Hemorrhage
6%
Dermatological Agent
6%
Somatomedin C Receptor
6%
Carcinoma
6%
Mammalian Target of Rapamycin Inhibitor
6%
Renal Cell Carcinoma
6%
Abdominal Wall Hernia
6%
Mitogen Activated Protein Kinase
6%
Sulindac
6%
Atorvastatin
6%
Colorectal Adenoma
6%
Survival
5%
Malignant Neoplasm
5%
Vascular Tumor
5%
